NICE guidance - erectile dysfunction in type 2 diabetes
Last reviewed 01/2018
- NICE have issued guidance concerning the management of erectile dysfunction
in patients with type 2 diabetes:
- review the issue of erectile dysfunction with men annually
- provide assessment and education for men with erectile dysfunction to address contributory factors and treatment options
- pharmacological
management
- offer a phosphodiesterase-5 inhibitor (choosing the drug with the lowest acquisition cost), in the absence of contraindications, if erectile dysfunction is a problem
- if phosphodiesterase-5 inhibitors have been
unsuccessful
- following discussion, refer to a service offering other medical, surgical, or psychological management of erectile dysfunction
Reference: